August 2026
1. BISCETTI F, Rando MM, Nicolazzi MA, Polito G, et al
   PCSK9 Predicts Adverse Limb Outcomes After Endovascular Revascularization in Diabetic Chronic Limb-threatening Ischemia.
   Thromb Haemost. 2026;126:846-855.
   

   >> Share

   
   June 2026
2. ROSSON M, D'Oria M, Simion C, Simioni P, et al
   Critical Review of International Clinical Practice Guidelines Recommendations for Prevention, Diagnosis, and Management of Central Venous Catheter Thrombosis.
   Thromb Haemost. 2026;126:553-567.
   

   >> Share

   
   December 2025
3. CAMPELLO E, Zanetto A, Prokopenko Y, Ilich A, et al
   Activation of the Contact System and Intrinsic Pathway in Peripheral and Portal Venous Circulations in Liver Cirrhosis.
   Thromb Haemost. 2025;125:1195-1204.
   

   >> Share

   
   October 2025
4. LEE K, Cha MJ, Kwon I, Kim S, et al
   Monocyte/Macrophage Infiltration in Thrombus and Outcomes of Stroke Patients with Monocyte/Macrophage-dominant Thrombus.
   Thromb Haemost. 2025;125:1023-1034.
   

   >> Share

   
   September 2025
5. KONIGSBRUGGE O, Klauser-Braun R, Schmaldienst S, Lorenz M, et al
   Venous Thromboembolism and Vascular Access Thrombosis in Patients on Hemodialysis: Incidence, Risk Factors, and Use of Antithrombotic Agents.
   Thromb Haemost. 2025 Sep 24. doi: 10.1055/a-2700-6368.
   

   >> Share

   
   February 2025
6. DUAN Y, Qiu M, Na K, Liu D, et al
   Inflammatory and Bleeding Risks on Clinical Outcomes in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention.
   Thromb Haemost. 2025 Feb 4. doi: 10.1055/a-2531-3268.
   

   >> Share

   
   
7. ZHENG YY, Wu TT, Hou XG, Yang Y, et al
   Low HDL Cholesterol is Associated with Reduced Bleeding Risk in Patients who Underwent PCI: Findings from the PRACTICE Study.
   Thromb Haemost. 2025;125:178-187.
   

   >> Share

   
   January 2025
8. XIANG Y, Zhang P, Lai Y, Wang D, et al
   Risk Factors, Antithrombotic Management, and Long-Term Outcomes of Patients Undergoing Endovascular Treatment of Unruptured Intracranial Aneurysms.
   Thromb Haemost. 2025;125:58-68.
   

   >> Share

   
   December 2024
9. MOHR K, Neusius T, Barco S, Konstantinides S, et al
   Socio-Economic Burden of Pulmonary Embolism in Europe: Shifting Priorities and Challenges for Novel Reperfusion Strategies.
   Thromb Haemost. 2024 Dec 19. doi: 10.1055/a-2505-8711.
   

   >> Share

   
   
10. JANG JY, Ga-In Y, Jongwha A, Bae JS, et al
    Optimal Long-term Antiplatelet Regimen for Patients with High Ischaemic and Bleeding Risks After Percutaneous Coronary Intervention.
    Thromb Haemost. 2024 Dec 10. doi: 10.1055/a-2499-5458.
    

    >> Share

    
    September 2024
11. MUSIALEK P, Rosenfield K, Siddiqui AH, Grunwald IQ, et al
    Carotid Stenosis and Stroke: Medicines, Stents, Surgery-"Wait-and-See" or Protect?
    Thromb Haemost. 2024;124:815-827.
    

    >> Share

    
    June 2024
12. CATTANEO M, Squizzato A, Birocchi S, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2024;124:595-597.
    

    >> Share

    
    
13. UEKI Y, Haner JD, Losdat S, Gargiulo G, et al
    Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial.
    Thromb Haemost. 2024;124:517-527.
    

    >> Share

    
    May 2024
14. LANDOLINA D, Ammirabile N, Capodanno D
    Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances.
    Thromb Haemost. 2024;124:497-499.
    

    >> Share

    
    
15. BIROCCHI S, Rocchetti M, Minardi A, Podda GM, et al
    Guided Anti-P2Y12 Therapy in Patients Undergoing PCI: Three Systematic Reviews with Meta-analyses of Randomized Controlled Trials with Homogeneous Design.
    Thromb Haemost. 2024;124:482-496.
    

    >> Share

    
    March 2024
16. ORTEGA-PAZ L, Franchi F, Rollini F, Galli M, et al
    Switching from Dual Antiplatelet Therapy with Aspirin Plus a P2Y12 Inhibitor to Dual Pathway Inhibition with Aspirin Plus Vascular-Dose Rivaroxaban: The Switching Anti-Platelet and Anti-Coagulant Therapy (SWAP-AC) Study.
    Thromb Haemost. 2024;124:263-273.
    

    >> Share

    
    December 2023
17. YE Y, Hao Y, Zhao X, Liu J, et al
    Percutaneous coronary intervention in acute coronary syndrome with mild-to-moderate thrombocytopenia.
    Thromb Haemost. 2023 Dec 11. doi: 10.1055/a-2225-5263.
    

    >> Share

    
    October 2023
18. PEDERSEN OB, Hvas AM, Pasalic L, Kristensen SD, et al
    Platelet Function and Maturity and Related microRNA Expression in Whole Blood in Patients with ST-Segment Elevation Myocardial Infarction.
    Thromb Haemost. 2023 Oct 16. doi: 10.1055/s-0043-1776305.
    

    >> Share

    
    September 2023
19. BONGIOVANNI D, Novelli L, Condello F, Kirmes K, et al
    Reticulated Platelets Predict Cardiovascular Death and Adverse Events in Coronary Artery Disease: A Systematic Review and Meta-analysis.
    Thromb Haemost. 2023 Sep 11. doi: 10.1055/s-0043-1773763.
    

    >> Share

    
    August 2023
20. HE HM, Chen YN, Zeng JL, Zheng SW, et al
    The Prognostic Value of the Age-D-Dimer-Albumin Score in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 29. doi: 10.1055/s-0043-1773764.
    

    >> Share

    
    
21. LAHU S, Adler K, Mayer K, Hein-Rothweiler R, et al
    Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention.
    Thromb Haemost. 2023 Aug 17. doi: 10.1055/s-0043-1772221.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share